IncFact
Company Profiles: Revenue, Growth, Competition

INCYTE Revenue, Growth & Competitor Profile

Last updated:

Company Awards

Big Fish
Big Fish
 
Public Company
public company
Brain Power (IP)
Patent/Trademark IP
 

Company Profile & Annual Report for Incyte

Access the complete profile.

Incyte Fast Facts

RevenueOver $500 million    See Exact Annual Revenue
Employees500 - 1,000Exact Company Size
Primary Industry5417 Scientific Research & Development Services
Additional NAICS Codes325412 Pharmaceutical Preparation Manufacturing
Address1801 Augustine Cut-off
Wilmington, DE 19803

www.incyte.com


Incyte's annual revenues are over $500 million (see exact revenue data) and has 500-1,000 employees. It is classified as operating in the Scientific Research & Development Services industry.


Incyte's Annual Report & Profile shows critical firmographic facts:
  • What is the company's size? (Annual sales and employees)
  • What industry is the company in?

Incyte is a publicly traded company on NASDAQ using the ticker symbol INCY. Detailed information on company financials and operating reports can be found here: NASDAQ: INCY



Incyte Annual Revenue and Growth Rate

Incyte Revenue Est.
($ Million)
Growth Rate (%)# Employees
2016 Details in Premium Report
2015
2014
2013
2012


1-Year Growth Rate:
3-Year Growth Rate (CAGR):
Premium Report

Note: Incyte's revenues are gauged from an analysis of company filings.



Trademark Applications

Trademark applications show the products and services that Incyte is developing and marketing. Incyte's new tradmarks suggest it is investing in R&D and marketing, while expanding into new products or markets. Trademarks may include brand names, product names, logos and slogans.

Trademark Date
PEMAZYRE
pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for the treatment of immunological disorders; pharmaceutical preparations for the treatment of hematological disorders; pharmaceutical preparations for the treatment of hypophosphatemia disorders; pharmaceutical preparations for the treatment of myeloproliferative disorders; pharmaceutical preparations for the treatment of skeletal or chondrocyte disorders
03/06/2018
FARGEFRIS
pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for the treatment of immunological disorders; pharmaceutical preparations for the treatment of hematological disorders; pharmaceutical preparations for the treatment of hypophosphatemia disorders; pharmaceutical preparations for the treatment of myeloproliferative disorders; pharmaceutical preparations for the treatment of skeletal or chondrocyte disorders
03/06/2018
FORLIWU
pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for the treatment of immunological disorders; pharmaceutical preparations for the treatment of hematological disorders; pharmaceutical preparations for the treatment of hypophosphatemia disorders; pharmaceutical preparations for the treatment of myeloproliferative disorders; pharmaceutical preparations for the treatment of skeletal or chondrocyte disorders
03/06/2018

See all trademarks and details in the Full Report.


Patent Applications

Patent applications show Incyte's intellectual property, its current capabilities and future direction. Incyte has applied for 223 patents since 2009. Incyte's most recent patent was filed in June 2018 for Immunomodulator Compounds And Methods Of Use. Compositions and methods for inducing PD-L1 internalization are disclosed. The methods include reducing the amount of cell surface PD-L1 by contacting a cell expressing PD-L1 with a compound that binds to cell surface PD-L1 and induces PD-L1 internalization. Compounds that induce PD-L1 internalization can be used to enhance, stimulate and/or increase an immune response and treat a PD-1-related disease or condition.


Patent Application Date
Complete list of patent applications




Recession Risk

Determine whether Incyte grew or shrank during the last recession. This is useful in estimating the financial strength and credit risk of the company. Compare how recession-proof Incyte is relative to the industry overall. While a new recession may strike a particular industry, measuring the industry and company's robustness during the last recession estimates its ability to weather future recessions.



Market Share of Competition: Incyte vs. Largest Competitors

A competitive analysis shows these companies are in the same general field as Incyte, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company HeadquartersRevenue ($ MM)
SYNEOS HEALTHRaleigh, NC100 
ALEXION PHARMACEUTICALSNew Haven, CT88 
LEIDOS HOLDINGSReston, VA79 
CEPHALONFrazer, PA70 
VERTEX PHARMACEUTICALSBoston, MA61 
NATIONAL TECHNOLOGY & ENGINEERING SOLUTIONS OF SANDIAAlbuquerque, NM59 




Nearby Competitors

These companies are similar in business line and location to Incyte. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company HeadquartersRevenue ($ MM)
INCYTEWilmington, DE100 
INTERDIGITAL COMMUNICATIONSWilmington, DE23 
ADVANCED MATERIALS TECHNOLOGYWilmington, DE0 
COMPACT MEMBRANE SYSTEMSNewport, DE0 
ANALYTICAL BIOLOGICAL SERVICESWilmington, DE0 
BYTEDANCEWilmington, DE0 




Similar Sized Companies near Wilmington

These are similar in size and location to Incyte.

Company HeadquartersRevenue ($ MM)
INDEPENDENT SCHOOL GROUP LIFE & DISABILITY INSURANCE TRUSTWilmington, DE16 
IKO INDUSTRIESWilmington, DE20 
DELPHI FINANCIAL GROUP INC/DEWilmington, DE20 
CHEMOURSWilmington, DE74 
ASTRAZENECA PHARMACEUTICALSWilmington, DE97 
E. I. DU PONT DE NEMOURSWilmington, DE100 
CHRISTIANA CARE HEALTH SERVICESWilmington, DE15 
AMERICAN EXPRESS CREDITWilmington, DE14 
SOLENISWilmington, DE10 
CHESAPEAKE & DELAWARE BREWINGWilmington, DE8 
DURAFIBER TECHNOLOGIES DFT OPERATIONSWilmington, DE7 
WILMINGTON TRUST CIT FOR EMPLOYEE BENEFIT PLANSWilmington, DE5 




Fastest Growing Competitors

These companies are in the same general field as Incyte and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

CompanyRevenue ($ MM)
Incyte Competitors